slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 45,691-45,720
Pages 10,126
Rows per page 30
Component
45,691-45,720 of 303,780
18
The slide uses a central vertical process flow with branching inputs and outputs.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 2 hits
19
The slide uses a timeline-like axis to represent 'Rank' and shows the shift in target positioning based on prompt precision.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 2 hits
20
The slide uses a numbered process flow mapped to a screenshot of a research interface.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 2 hits
22
Uses information theory to illustrate exponential search space reduction.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Aha Moment2 hits
24
The scatter plot demonstrates the 'active learning' selection process vs standard coverage properties.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Aha Moment2 hits
25
The slide uses a horizontal layout to showcase four distinct technical pillars of the company's R&D infrastructure.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
26
The slide uses a process flow diagram showing the transition from Target Product Profile (table) to MPO (code snippet) to Merit (scatter plot).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
27
The diagram illustrates a multi-modal AI pipeline for drug discovery, emphasizing flexibility in data inputs and model architectures.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
29
MD stands for Molecular Dynamics. The slide features a 3D protein-ligand binding visualization.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
30
The slide uses a pyramid framework to show the progression of data and process maturity.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
32
The diagram is a classic flywheel or continuous improvement loop.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
33
Includes a process flow diagram for Chemical Synthesis, Compound Management, and Biological Testing.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
35
The slide uses an isometric technical illustration to depict a modular lab setup.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
37
The slide uses a process flow diagram to map specific robotic solutions to different stages of laboratory automation.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
39
The slide uses a circular process flow to represent a proprietary R&D pipeline.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)2 hits
41
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
42
The slide uses a converging timeline/process flow to show how different patient types (Ovarian cancer vs AML) feed into a unified precision medicine testing platform.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
43
Uses a complex heatmap/dot-plot visualization to show drug sensitivity across different samples and cell lines.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
44
The slide uses a small multiples approach to show individual patient responses, then aggregates them into two groups (I and II) to demonstrate differential sensitivity.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
48
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
49
The slide uses a human anatomy diagram to map specific cancer types to their locations, providing a visual representation of the addressable market.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
50
Includes a biological pathway diagram and a list of potential cancer indications.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
51
The slide uses a three-column layout to define the target product profile (TPP) for a CDK7 inhibitor.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
52
The slide uses a color-coded heatmap to visualize performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
53
Data source: Besnard et al, AACR (2022).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
54
The slide uses two distinct charts to correlate drug exposure time with physiological toxicity (body weight change).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
55
The chart displays sensitivity across 60+ samples. The right side shows a volcano plot for pathway analysis and a conceptual diagram for combination testing.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
56
The slide uses a waterfall plot for single-agent sensitivity and a heatmap for combination synergy, highlighting specific patient response rates for different mechanisms of action.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
57
Includes a Venn diagram and two line charts showing Log2FoldChange vs concentration.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits
59
The chart compares % Reduction PLN Weight across different doses of EXS4318 versus a failed competitor drug.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction2 hits